Torsemide renal clearance and genetic variation in luminal and basolateral organic anion transporters

British Journal of Clinical Pharmacology

Volumn 62, Issue 3, 2006, Pages 323-335

  Vormfelde, Stefan V ^a   Schirmer, Markus ^a   Hagos, Yohannes ^b   Toliat, Mohammad R ^c   Engelhardt, Sabine ^a   Meineke, Ingolf ^a   Burckhardt, Gerhard ^b   Nürnberg, Peter ^c   Brockmöller, Jürgen ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

^c UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Haplotype; Organic anion transporter; Polymorphism; Renal clearance; SLC22A11; Torsemide

Indexed keywords

ORGANIC ANION TRANSPORTER; ORGANIC ANION TRANSPORTER 1; ORGANIC ANION TRANSPORTER 3; ORGANIC ANION TRANSPORTER 4; TORASEMIDE;

ADULT; ARTICLE; BASOLATERAL MEMBRANE; CELL STRAIN HEK293; CONTROLLED STUDY; GENE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HAPLOTYPE; HOMOZYGOTE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; KIDNEY CLEARANCE; MALE; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SLC22A11 GENE; SLC22A6 GENE; SLC22A8 GENE;

ADULT; DIURETICS; GENETIC LINKAGE; GENETIC VARIATION; HAPLOTYPES; HUMANS; KIDNEY; LINKAGE (GENETICS); MALE; MIDDLE AGED; ORGANIC ANION TRANSPORTERS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; SULFONAMIDES; VARIATION (GENETICS);

EID: 33747068033     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2006.02655.x     Document Type: Article

References (25)

1. Mizuno N, Niwa T, Yotsumoto Y, Sugiyama Y. Impact of drug transporter studies on drug discovery and development. Pharmacol Rev 2003; 55: 425-61.
2. van Montfoort JE, Hagenbuch B, Groothuis GM, Koepsell H, Meier PJ, Meijer DK. Drug uptake systems in liver and kidney. Curr Drug Metab 2003; 4: 185-211.
3. Hediger MA, Romero MF, Peng JB, Rolfs A, Takanaga H, Bruford EA. The ABCs of solute carriers: physiological, pathological and therapeutic implications of human membrane transport proteins. Introduction. Pflugers Arch 2004; 447: 465-8.
4. Leabman MK, Huang CC, DeYoung J, Carlson EJ, Taylor TR, de la Cruz M, Johns SJ, Stryke D, Kawamoto M, Urban TJ, Kroetz DL, Ferrin TE, Clark AG, Risch N, Herskowitz I, Giacomini KM. Natural variation in human membrane transporter genes reveals evolutionary and functional constraints. Proc Natl Acad Sci USA 2003; 100: 5896-901.
5. Koepsell H, Endou H. The SLC22 drug transporter family. Pflugers Arch 2004; 447: 666-76.
6. Burckhardt G, Bahn A, Wolff NA. Molecular physiology of renal p-aminohippurate secretion. News Physiol Sci 2001; 16: 114-8.
7. Miyazaki H, Sekine T, Endou H. The multispecific organic anion transporter family: properties and pharmacological significance. Trends Pharmacol Sci 2004; 25: 654-62.
8. Vormfelde SV, Burckhardt G, Zirk A, Wojnowski L, Brockmoller J. Pharmacogenomics of diuretic drugs: data on rare monogenic disorders and on polymorphisms and requirements for further research. Pharmacogenomics 2003; 4: 701-34.
9. Burckhardt BC, Burckhardt G. Transport of organic anions across the basolateral membrane of proximal tubule cells. Rev Physiol Biochem Pharmacol 2003; 146: 95-158.
10. Wright SH, Dantzler WH. Molecular and cellular physiology of renal organic cation and anion transport. Physiol Rev 2004; 84: 987-1049.
11. Hasannejad H, Takeda M, Taki K, Shin HJ, Babu E, Jutabha P, Khamdang S, Aleboyeh M, Onozato ML, Tojo A, Enomoto A, Anzai N, Narikawa S, Huang XL, Niwa T, Endou H. Interactions of human organic anion transporters with diuretics. J Pharmacol Exp Ther 2004; 308: 1021-9.
12. Lohrmann E, Burhoff I, Greger R. Tubular effects of the diuretic torasemide. Cardiology 1994; 84 (Suppl. 2): 135-42.
13. Vormfelde SV, Engelhardt S, Zirk A, Meineke I, Tuchen F, Kirchheiner J, Brockmoller J. CYP2C9 polymorphisms and the interindividual variability in pharmacokinetics and pharmacodynamics of the loop diuretic drug torsemide. Clin Pharmacol Ther 2004; 76: 557-66.
14. Iida A, Saito S, Sekine A, Mishima C, Kondo K, Kitamura Y, Harigae S, Osawa S, Nakamura Y. Catalog of 258 single-nucleotide polymorphisms (SNPs) in genes encoding three organic anion transporters, three organic anion-transporting polypeptides, and three NADH:ubiquinone oxidoreductase flavoproteins. J Hum Genet 2001; 46: 668-83.
15. Bleasby K, Hall LA, Perry JL, Mohrenweiser HW, Pritchard JB. Functional consequences of single nucleotide polymorphisms in the human organic anion transporter hOAT1 (SLC22A6). J Pharmacol Exp Ther 2005; 314: 923-31.
16. Ahmadi KR, Weale ME, Xue ZY, Soranzo N, Yarnall DP, Briley JD, Maruyama Y, Kobayashi M, Wood NW, Spurr NK, Burns DK, Roses AD, Saunders AM, Goldstein DB. A single-nucleotide polymorphism tagging set for human drug metabolism and transport. Nat Genet 2005; 37: 84-9.
17. Fujita T, Brown C, Carlson EJ, Taylor T, de la Cruz M, Johns SJ, Stryke D, Kawamoto M, Fujita K, Castro R, Chen CW, Lin ET, Brett CM, Burchard EG, Ferrin TE, Huang CC, Leabman MK, Giacomini KM. Functional analysis of polymorphisms in the organic anion transporter, SLC22A6 (OAT1). Pharmacogenet Genomics 2005; 15: 201-9.
18. Nishizato Y, Ieiri I, Suzuki H, Kimura M, Kawabata K, Hirota T, Takane H, Irie S, Kusuhara H, Urasaki Y, Urae A, Higuchi S, Otsubo K, Sugiyama Y. Polymorphisms of OATP-C (SLC21A6) and OAT3 (SLC22A8) genes: consequences for pravastatin pharmacokinetics. Clin Pharmacol Ther 2003; 73: 554-65.
19. Bakhiya N, Stephani M, Bahn A, Ugele B, Seidel A, Burckhardt G, Glatt H. Uptake of chemically reactive, DNA-damaging sulfuric esters into renal cells by human organic anion transporters. J Am Soc Nephrol; in press.
20. Engelhardt S, Meineke I, Brockmoller J. Improved solid-phase extraction and HPLC measurement of torasemide and its important metabolites. J Chromatogr B Analyt Technol Biomed Life Sci 2006; 831: 31-5.
21. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263-5.
22. Lewontin RC. The Interaction of selection and linkage. Ii Optimum models. Genetics 1964; 50: 757-82.
23. Zeggini E, Barton A, Eyre S, Ward D, Ollier W, Worthington J, John S. Characterisation of the genomic architecture of human chromosome 17q and evaluation of different methods for haplotype block definition. BMC Genet 2005; 6: 21.
24. Stephens M, Donnelly P. A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 2003; 73: 1162-9.
25. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001; 68: 978-89.